Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arthur Krieg Insider Profile
4 Followers
Arthur Krieg, SVP, Chief Scientific Officer at Sarepta Therapeutics, holds 0.00 shares in Sarepta Therapeutics (Ticker: SRPT), holds 815.73K shares in Checkmate Pharmaceuticals (Ticker: CMPI). Most recently, Arthur Krieg ― shares of Sarepta Therapeutics on ― for an estimated value of ―.
Arthur Krieg Sarepta Therapeutics (SRPT)SVP, Chief Scientific Officer
Sarepta Therapeutics (SRPT)
SVP, Chief Scientific Officer
Ranked #87,332 out of 98,564 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-25.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Arthur Krieg does not currently own shares as a corporate insider.
A breakdown of Arthur Krieg's holdings
Insider Roles
SVP, Chief Scientific Officer
Roles that Arthur Krieg holds in companies
Most Profitable Insider Trade
Stock:
Checkmate Pharmaceuticals
(CMPI)
(CMPI)
Rating:Informative Buy
Date:Jun 21, 2021 - Jun 21, 2022
Return:+74.70%
The most profitable trade made by Arthur Krieg
Arthur Krieg's Trading History
Sarepta Therapeutics
―
SVP, Chief Scientific Officer
―
$0.00
Checkmate Pharmaceuticals
Jun 21, 2021
―
Informative Buy
43.63K
$8.57M
List of latest transactions for each holding click on a transaction to see Arthur Krieg's performance on stock
You May Also Like
Arthur Krieg insider profile FAQ
What is the percentage of profitable transactions made by Arthur Krieg?
The percentage of profitable transactions made by Arthur Krieg is 38%.
What is the average return per transaction made by Arthur Krieg?
The average return per transaction made by Arthur Krieg is -25.70%.
What stocks does Arthur Krieg hold?
Arthur Krieg holds: SRPT, CMPI stocks.
What was Arthur Krieg’s latest transaction?
Arthur Krieg latest transaction was an Uninformative Buy of ―.
What was Arthur Krieg's most profitable transaction?
Arthur Krieg’s most profitable transaction was an Informative Buy of CMPI stock on June 21, 2021. The return on the trade was 74.70%.
What is Arthur Krieg's role in Sarepta Therapeutics?
Arthur Krieg's role in Sarepta Therapeutics is SVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.